CMLHope.Com
A Worldwide Support Network For Chronic Myelogenous Leukemia
Posted by rob on April 13, 2007 under Uncategorized | Be the First to Comment
Preclinical pharmacokinetics and in vitro metabolism of dasatinib (BMS-354825): a potent oral multi-targeted kinase inhibitor against SRC and BCR-ABL.
Clinical and Imaging Characteristics of Orbital Leukemic Tumors.
You must be logged in to post a comment.
Add A Comment
You must be logged in to post a comment.